The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
H1N1 Vaccines-Global Market Insights and Sales Trends 2025
Synopsis
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market size is expected to reach US$ 5708.3 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of H1N1 Vaccines in various end use industries. The expanding demands from the Influenza, Meningococcal, Cervical Cancer and Pneumococcal, are propelling H1N1 Vaccines market. Intramuscular Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intranasal Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global H1N1 Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global H1N1 Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, H1N1 Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of H1N1 Vaccines covered in this report include Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla and Merck, etc.
The global H1N1 Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Global H1N1 Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global H1N1 Vaccines market, Segment by Type:
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Global H1N1 Vaccines market, by Application
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of H1N1 Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market size is expected to reach US$ 5708.3 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of H1N1 Vaccines in various end use industries. The expanding demands from the Influenza, Meningococcal, Cervical Cancer and Pneumococcal, are propelling H1N1 Vaccines market. Intramuscular Vaccines, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intranasal Vaccines segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for H1N1 Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global H1N1 Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global H1N1 Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, H1N1 Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of H1N1 Vaccines covered in this report include Abbott, Baxter International, Sanofi, GSK, Pfizer, Mitsubishi Tanabe Pharma, Hualan Biological Engineering, Cipla and Merck, etc.
The global H1N1 Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
Global H1N1 Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global H1N1 Vaccines market, Segment by Type:
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Global H1N1 Vaccines market, by Application
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of H1N1 Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of H1N1 Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 H1N1 Vaccines Market Overview
1.1 H1N1 Vaccines Product Overview
1.2 H1N1 Vaccines Market Segment by Type
1.2.1 Intramuscular Vaccines
1.2.2 Intranasal Vaccines
1.2.3 Intradermal Vaccines
1.3 Global H1N1 Vaccines Market Size by Type
1.3.1 Global H1N1 Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global H1N1 Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global H1N1 Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America H1N1 Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe H1N1 Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific H1N1 Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America H1N1 Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa H1N1 Vaccines Sales Breakdown by Type (2018-2023)
2 Global H1N1 Vaccines Market Competition by Company
2.1 Global Top Players by H1N1 Vaccines Sales (2018-2023)
2.2 Global Top Players by H1N1 Vaccines Revenue (2018-2023)
2.3 Global Top Players by H1N1 Vaccines Price (2018-2023)
2.4 Global Top Manufacturers H1N1 Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 H1N1 Vaccines Market Competitive Situation and Trends
2.5.1 H1N1 Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by H1N1 Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in H1N1 Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into H1N1 Vaccines Market
2.8 Key Manufacturers H1N1 Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 H1N1 Vaccines Status and Outlook by Region
3.1 Global H1N1 Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global H1N1 Vaccines Historic Market Size by Region
3.2.1 Global H1N1 Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global H1N1 Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global H1N1 Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global H1N1 Vaccines Forecasted Market Size by Region
3.3.1 Global H1N1 Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global H1N1 Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global H1N1 Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global H1N1 Vaccines by Application
4.1 H1N1 Vaccines Market Segment by Application
4.1.1 Influenza
4.1.2 Meningococcal
4.1.3 Cervical Cancer
4.1.4 Pneumococcal
4.1.5 Hepatitis
4.1.6 Measles
4.1.7 Mumps
4.1.8 Rubella
4.1.9 Others
4.2 Global H1N1 Vaccines Market Size by Application
4.2.1 Global H1N1 Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global H1N1 Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global H1N1 Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America H1N1 Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe H1N1 Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific H1N1 Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America H1N1 Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa H1N1 Vaccines Sales Breakdown by Application (2018-2023)
5 North America H1N1 Vaccines by Country
5.1 North America H1N1 Vaccines Historic Market Size by Country
5.1.1 North America H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America H1N1 Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America H1N1 Vaccines Sales in Value by Country (2018-2023)
5.2 North America H1N1 Vaccines Forecasted Market Size by Country
5.2.1 North America H1N1 Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America H1N1 Vaccines Sales in Value by Country (2024-2029)
6 Europe H1N1 Vaccines by Country
6.1 Europe H1N1 Vaccines Historic Market Size by Country
6.1.1 Europe H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe H1N1 Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe H1N1 Vaccines Sales in Value by Country (2018-2023)
6.2 Europe H1N1 Vaccines Forecasted Market Size by Country
6.2.1 Europe H1N1 Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe H1N1 Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific H1N1 Vaccines by Region
7.1 Asia-Pacific H1N1 Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific H1N1 Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific H1N1 Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific H1N1 Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific H1N1 Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific H1N1 Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific H1N1 Vaccines Sales in Value by Region (2024-2029)
8 Latin America H1N1 Vaccines by Country
8.1 Latin America H1N1 Vaccines Historic Market Size by Country
8.1.1 Latin America H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America H1N1 Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America H1N1 Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America H1N1 Vaccines Forecasted Market Size by Country
8.2.1 Latin America H1N1 Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America H1N1 Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa H1N1 Vaccines by Country
9.1 Middle East and Africa H1N1 Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa H1N1 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa H1N1 Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa H1N1 Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa H1N1 Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa H1N1 Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa H1N1 Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott H1N1 Vaccines Products Offered
10.1.5 Abbott Recent Development
10.2 Baxter International
10.2.1 Baxter International Company Information
10.2.2 Baxter International Introduction and Business Overview
10.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter International H1N1 Vaccines Products Offered
10.2.5 Baxter International Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Introduction and Business Overview
10.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi H1N1 Vaccines Products Offered
10.3.5 Sanofi Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GSK H1N1 Vaccines Products Offered
10.4.5 GSK Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer H1N1 Vaccines Products Offered
10.5.5 Pfizer Recent Development
10.6 Mitsubishi Tanabe Pharma
10.6.1 Mitsubishi Tanabe Pharma Company Information
10.6.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products Offered
10.6.5 Mitsubishi Tanabe Pharma Recent Development
10.7 Hualan Biological Engineering
10.7.1 Hualan Biological Engineering Company Information
10.7.2 Hualan Biological Engineering Introduction and Business Overview
10.7.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hualan Biological Engineering H1N1 Vaccines Products Offered
10.7.5 Hualan Biological Engineering Recent Development
10.8 Cipla
10.8.1 Cipla Company Information
10.8.2 Cipla Introduction and Business Overview
10.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cipla H1N1 Vaccines Products Offered
10.8.5 Cipla Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck H1N1 Vaccines Products Offered
10.9.5 Merck Recent Development
10.10 Sinovac Biotech
10.10.1 Sinovac Biotech Company Information
10.10.2 Sinovac Biotech Introduction and Business Overview
10.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sinovac Biotech H1N1 Vaccines Products Offered
10.10.5 Sinovac Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 H1N1 Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 H1N1 Vaccines Industrial Chain Analysis
11.4 H1N1 Vaccines Market Dynamics
11.4.1 H1N1 Vaccines Industry Trends
11.4.2 H1N1 Vaccines Market Drivers
11.4.3 H1N1 Vaccines Market Challenges
11.4.4 H1N1 Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 H1N1 Vaccines Distributors
12.3 H1N1 Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
